Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives
Langue
EN
Article de revue
Ce document a été publié dans
Immunotherapy. 2024, vol. 16, n° 3, p. 187 – 197
Résumé en anglais
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of several solid cancers, including head and neck squamous cell carcinoma (HNSCC). First approved for second-line settings, ICIs are now used for the ...Lire la suite >
Mots clés en anglais
HPV
PD-L1
Adjuvant
Head and neck squamous cell carcinoma
Immune checkpoint inhibitors
Locally advanced
Metastatic
Neoadjuvant
Predictive biomarker
Treatment combination